Home › NDC Lookup › RxCUI directory › RxCUI 2055751

Bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG / pramoxine hydrochlo... — RxCUI 2055751

Name: Bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG / pramoxine hydr… (RxCUI 2055751)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2055751 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2055751

Official nameBacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asbacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT / pramoxine HCl 10 MG per GM Topical Ointment

FDA products mapped3

Package NDCs mapped3

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bacitracin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It is first aid to help prevent infection in minor cuts, scrapes, and burns. One cream product also has directions for athlete's foot, ringworm and jock itch.
Clean the area, then put on a small amount, about the size of your fingertip. Do this 1 to 3 times a day, and you can cover it with a sterile bandage. One cream product is used as...
Not longer than 1 week unless a doctor tells you to. If the problem is not getting better or gets worse, stop and check with a doctor.
Stop if you get a rash or any allergic reaction, and talk to a doctor. Don't use it if you are allergic to any ingredient.

📖 Read our full Bacitracin Topical guide →

🕸️ Concept Web — How Bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG /... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment RxCUI 2055751 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 6

The active substance itself — no strength, form, or brand attached yet.
- Bacitracin 1291 IN
- Neomycin 7299 IN
- Polymyxin B 8536 IN
- Pramoxine 34347 IN
- Bacitracin / neomycin / polymyxin B / pramoxine 466540 MIN
- Pramoxine hydrochloride 57555 PIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Bacitracin / neomycin / polymyxin B / pramoxine Topical Ointment 374798 SCDF
- Bacitracin / neomycin / polymyxin B / pramoxine hydrochloride Topical Ointment 2645927 SCDFP
- Bacitracin / neomycin / polymyxin B / pramoxine Topical Product 1155349 SCDG
- Bacitracin / neomycin / polymyxin B / pramoxine hydrochloride Topical Product 2662300 SCDGP
- Topical Ointment 316985 DF
- Topical Product 1151122 DFG
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Bacitracin 0.5 UNT/MG 315454 SCDC
- Neomycin 0.0035 MG/MG 328185 SCDC
- Polymyxin B 5 UNT/MG 335956 SCDC
- Pramoxine hydrochloride 0.01 MG/MG 995190 SCDC

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Bacitracin 0.5 UNT/MG SCDC · 315454
Neomycin 0.0035 MG/MG SCDC · 328185
Polymyxin B 5 UNT/MG SCDC · 335956
Pramoxine hydrochloride 0.01 MG/MG SCDC · 995190
Bacitracin / neomycin / polymyxin B / pramoxine Topical Ointment SCDF · 374798
Bacitracin / neomycin / polymyxin B / pramoxine hydrochloride Topical Ointment SCDFP · 2645927
Bacitracin / neomycin / polymyxin B / pramoxine Topical Product SCDG · 1155349
Bacitracin / neomycin / polymyxin B / pramoxine hydrochloride Topical Product SCDGP · 2662300

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 2055751 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
61010-4401-01	28.4 g in 1 TUBE (61010-4401-1)	Triple Antibiotic with Pain Relief	Safetec of America, Inc.	2019-11-01
69729-0615-05	1 TUBE in 1 BOX (69729-615-05) / 14 g in 1 TUBE (69729-615-...	PENIMIXCINA	OPMX LLC	2018-09-05
69729-0616-61	1 TUBE in 1 BOX (69729-616-61) / 14 g in 1 TUBE (69729-616-...	PENTREXCILINA TRIPLE ANTIBIOTIC PLUS PAIN RELIEF	OPMX LLC	2018-09-05

Observed labelers: OPMX LLC (2) · Safetec of America, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.